In 2016, DDTD has reached two milestones in its fight against tropical diseases:
(a) the first rapid diagnostic test fully developed in-house
(b) the first collaboration with a major pharmaceutical company
Rapid Diagnostic Test for Loa Loa
With support from the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the Wellcome Trust, and of generous philanthropists, DDTD has generated a rapid diagnostic test to detect exposure to loa loa.
Loa loa is a parasitic worm that infects 3-40 million people in sub-Saharan Africa and which represents a major public health issue. DDTD has developed the first commercial tests for the disease, with 50,000 units in stock as of May 2017.
Janssen Diagnostics Collaboration on River Blindness
DDTD is proud to have been selected by Janssen Diagnostics, a Johnson & Johnson company, for an exploratory project on river blindness. Janssen Diagnostics has discovered new biomarkers for river blindness and entrusted DDTD with adapting them to a rapid test format. Results were made public at the 2016 Annual Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta, November 2016.
DDTD is deeply grateful to the individuals and funding agencies who have supported our mission.